Pharma News, 2019

While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn withou...

The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.

GlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an immuno-oncology drug that made a splash at last year’s ESMO meeting.

WASHINGTON – Senate Finance Committee Chairman Chuck Grassley of Iowa and Ranking Member Ron Wyden of Oregon today invited seven major pharmaceutical companies to testify before a committee hearing ...

Teva’s migraine drug Ajovy (fremanezumab) has moved closer to the EU market after the influential CHMP regulatory committee gave it the green light.

Hawaii may once again be at the nation’s forefront when it comes to setting smoking policy.

LONDON - A vaccine given to girls to protect them against a virus that causes cervical cancer is a “critical” health tool and access to it should be scaled up as swiftly as possible, especially in...

Sen.

NEW YORK & INDIANAPOLIS---- Pfizer Inc.

SAN DIEGO and CAMBRIDGE, Mass.

Research has shown a direct relationship between mutations in introns and variability in human populations.

A Duke Health pilot project suggests that in the near future, a blood test could show whether arteries carrying blood to the heart are narrow or blocked, a risk factor for heart disease.